CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Clinical trial NCT01493947 · COMPLETED

Trial details

NCT number: NCT01493947
Sponsor: Galderma R&D
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Papulopustular Rosacea

Start date: 2012-04-01
Primary completion: 2013-12-01
Enrollment: 962

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.